Clinical Trial Update: Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI [Phase 4]

View source ↗

Summary

Clinical trial update for Ivabradine in STEMI patients after primary PCI evaluating left ventricular remodeling during Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Qian geng | Conditions: Cardiovascular Diseases | Phase 4 | Status: UNKNOWN